Filing Details

Accession Number:
0001325812-11-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-13 16:57:53
Reporting Period:
2011-10-11
Filing Date:
2011-10-13
Accepted Time:
2011-10-13 16:57:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180432 John Maraganore 300 Third Street
Cambridge MA 02142
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-23 2,500 $0.00 47,500 No 5 G Direct
Common Stock Acquisiton 2011-10-11 1,480 $6.75 48,980 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,977 Indirect by Managed Account
Footnotes
  1. The purchases reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2011.
  2. Purchase prices ranged from $6.74 to $6.75.
  3. The reporting person owns 1,977 shares of ALNY common stock under the ALNY 401(k) Plan as a result of the ALNY 401(k) matching contribution program.